Correlation Between Sonos and Estrella Immunopharma

Can any of the company-specific risk be diversified away by investing in both Sonos and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonos and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonos Inc and Estrella Immunopharma, you can compare the effects of market volatilities on Sonos and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonos with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonos and Estrella Immunopharma.

Diversification Opportunities for Sonos and Estrella Immunopharma

0.56

Correlation Coefficient

Sonos  Estrella Immunopharma

Very weak diversification

The 3 months correlation between Sonos and Estrella is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Sonos Inc and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Sonos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonos Inc are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Sonos i.e., Sonos and Estrella Immunopharma go up and down completely randomly.

Pair Corralation between Sonos and Estrella Immunopharma

Given the investment horizon of 90 days Sonos Inc is expected to under-perform the Estrella Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Sonos Inc is 11.64 times less risky than Estrella Immunopharma. The stock trades about 0.0 of its potential returns per unit of risk. The Estrella Immunopharma is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  2.16  in Estrella Immunopharma on October 11, 2024 and sell it today you would earn a total of  6.94  from holding Estrella Immunopharma or generate 321.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	43.15%
Values	Daily Returns

Sonos Inc  vs.  Estrella Immunopharma

Sonos Inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sonos Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Sonos displayed solid returns over the last few months and may actually be approaching a breakup point.

Estrella Immunopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sonos and Estrella Immunopharma

The main advantage of trading using opposite Sonos and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonos position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.

The idea behind Sonos Inc and Estrella Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.